{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:51:08Z","timestamp":1791669068301,"version":"4.3.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["74344"],"award-info":[{"award-number":["74344"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12896-3","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:44:15Z","timestamp":1791668655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adropin signaling pathways in metabolic and non-metabolic disorders"],"prefix":"10.1007","volume":"53","author":[{"given":"Amir","family":"Valizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Mohammadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Danaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadije","family":"Meghrazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ghorbanihaghjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"1","key":"12896_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41514-021-00076-5","volume":"7","author":"S Banerjee","year":"2021","unstructured":"Banerjee S, Ghoshal S, Girardet C, DeMars KM, Yang C, Niehoff ML, Nguyen AD, Jayanth P, Hoelscher BA, Xu F et al (2021) Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging mice. npj Aging Mech Disease 7(1):23. https:\/\/doi.org\/10.1038\/s41514-021-00076-5","journal-title":"npj Aging Mech Disease"},{"issue":"6","key":"12896_CR2","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","volume":"8","author":"KG Kumar","year":"2008","unstructured":"Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M et al (2008) Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8(6):468\u2013481. https:\/\/doi.org\/10.1016\/j.cmet.2008.10.011","journal-title":"Cell Metab"},{"key":"12896_CR3","doi-asserted-by":"publisher","unstructured":"Ali II, D\u2019Souza C, Singh J, Adeghate E (2022) Adropin\u2019s Role in Energy Homeostasis and Metabolic Disorders. Int J Mol Sci 23(15). https:\/\/doi.org\/10.3390\/ijms23158318","DOI":"10.3390\/ijms23158318"},{"issue":"10","key":"12896_CR4","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.2337\/db14-0388","volume":"63","author":"S Gao","year":"2014","unstructured":"Gao S, McMillan RP, Jacas J, Zhu Q, Li X, Kumar GK, Casals N, Hegardt FG, Robbins PD, Lopaschuk GD et al (2014) Regulation of substrate oxidation preferences in muscle by the peptide hormone adropin. Diabetes 63(10):3242\u20133252. https:\/\/doi.org\/10.2337\/db14-0388","journal-title":"Diabetes"},{"key":"12896_CR5","doi-asserted-by":"publisher","unstructured":"Jasaszwili M, Billert M, Strowski MZ, Nowak KW, Skrzypski M (2020) Adropin as A Fat-Burning Hormone with Multiple Functions-Review of a Decade of Research. Molecules 25(3). https:\/\/doi.org\/10.3390\/molecules25030549","DOI":"10.3390\/molecules25030549"},{"issue":"11 Suppl","key":"12896_CR6","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1161\/circulationaha.109.931782","volume":"122","author":"F Lovren","year":"2010","unstructured":"Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, Al-Omran M, Teoh H, Verma S (2010) Adropin is a novel regulator of endothelial function. Circulation 122(11 Suppl):S185\u2013S192. https:\/\/doi.org\/10.1161\/circulationaha.109.931782","journal-title":"Circulation"},{"issue":"10","key":"12896_CR7","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1210\/jc.2012-2194","volume":"97","author":"AA Butler","year":"2012","unstructured":"Butler AA, Tam CS, Stanhope KL, Wolfe BM, Ali MR, O\u2019Keeffe M, St-Onge MP, Ravussin E, Havel PJ (2012) Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab 97(10):3783\u20133791. https:\/\/doi.org\/10.1210\/jc.2012-2194","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"12896_CR8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/oby.2012.31","volume":"20","author":"K Ganesh Kumar","year":"2012","unstructured":"Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, Culler MD, Mynatt RL, Butler AA (2012) Adropin deficiency is associated with increased adiposity and insulin resistance. Obes (Silver Spring) 20(7):1394\u20131402. https:\/\/doi.org\/10.1038\/oby.2012.31","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"12896_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12902-023-01327-0","volume":"23","author":"S Soltani","year":"2023","unstructured":"Soltani S, Beigrezaei S, Malekahmadi M, Clark CCT, Abdollahi S (2023) Circulating levels of adropin and diabetes: a systematic review and meta-analysis of observational studies. BMC Endocr Disord 23(1):73. https:\/\/doi.org\/10.1186\/s12902-023-01327-0","journal-title":"BMC Endocr Disord"},{"issue":"36","key":"12896_CR10","doi-asserted-by":"publisher","first-page":"13366","DOI":"10.1074\/jbc.RA119.008967","volume":"294","author":"S Gao","year":"2019","unstructured":"Gao S, Ghoshal S, Zhang L, Stevens JR, McCommis KS, Finck BN, Lopaschuk GD, Butler AA (2019) The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity. J Biol Chem 294(36):13366\u201313377. https:\/\/doi.org\/10.1074\/jbc.RA119.008967","journal-title":"J Biol Chem"},{"issue":"4","key":"12896_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molmet.2015.01.005","volume":"4","author":"S Gao","year":"2015","unstructured":"Gao S, McMillan RP, Zhu Q, Lopaschuk GD, Hulver MW, Butler AA (2015) Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab 4(4):310\u2013324. https:\/\/doi.org\/10.1016\/j.molmet.2015.01.005","journal-title":"Mol Metab"},{"key":"12896_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102196","author":"JR Stevens","year":"2025","unstructured":"Stevens JR, Girardet C, Zhou M, Gamie F, Aggarwal G, McMillan RP, Hulver MW, Martinez LO, van der Brug M, Vellas B et al (2025) Adropin expression reflects circadian, lipoprotein, and mitochondrial processes in human tissues. Mol Metab 99102196. https:\/\/doi.org\/10.1016\/j.molmet.2025.102196","journal-title":"Mol Metab 99102196"},{"key":"12896_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-026-05656-9","author":"G Garousi","year":"2026","unstructured":"Garousi G, Alimohammadi S, Zendehdel M, Hassanpour S (2026) Modulation of feeding behavior by central adropin injection in neonatal broiler chicks: evidence for NPY and melanocortin signaling pathways involvement. BMC Vet Res. https:\/\/doi.org\/10.1186\/s12917-026-05656-9","journal-title":"BMC Vet Res"},{"issue":"2","key":"12896_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.14336\/ad.2017.0523","volume":"9","author":"C Yang","year":"2018","unstructured":"Yang C, DeMars KM, Candelario-Jalil E (2018) Age-Dependent Decrease in Adropin is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain. Aging Dis 9(2):322\u2013330. https:\/\/doi.org\/10.14336\/ad.2017.0523","journal-title":"Aging Dis"},{"key":"12896_CR15","doi-asserted-by":"publisher","unstructured":"Yang C, Howell JA, Liu L, Gunraj RE, Candelario-Jalil E (2025) Changes in adropin levels in brain and peripheral tissues with aging. Neurosci Lett 850138150. https:\/\/doi.org\/10.1016\/j.neulet.2025.138150","DOI":"10.1016\/j.neulet.2025.138150"},{"issue":"1","key":"12896_CR16","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1186\/s12885-023-11519-5","volume":"23","author":"L Jia","year":"2023","unstructured":"Jia L, Liao L, Jiang Y, Hu X, Lu G, Xiao W, Gong W, Jia X (2023) Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression. BMC Cancer 23(1):1042. https:\/\/doi.org\/10.1186\/s12885-023-11519-5","journal-title":"BMC Cancer"},{"issue":"740","key":"12896_CR17","doi-asserted-by":"publisher","first-page":"eadd6570","DOI":"10.1126\/scitranslmed.add6570","volume":"16","author":"M Liang","year":"2024","unstructured":"Liang M, Dickel N, Gy\u00f6rfi AH, SafakT\u00fcmerdem B, Li YN, Rigau AR, Liang C, Hong X, Shen L, Matei AE et al (2024) Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis. Sci Transl Med 16(740):eadd6570. https:\/\/doi.org\/10.1126\/scitranslmed.add6570","journal-title":"Sci Transl Med"},{"issue":"6","key":"12896_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41584-024-01121-9","volume":"20","author":"R Phillips","year":"2024","unstructured":"Phillips R (2024) Adropin inhibits fibrosis in SSc. Nat Rev Rheumatol 20(6):319. https:\/\/doi.org\/10.1038\/s41584-024-01121-9","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"12896_CR19","doi-asserted-by":"publisher","first-page":"8659","DOI":"10.1038\/s41598-025-93215-x","volume":"15","author":"S Maurya","year":"2025","unstructured":"Maurya S, Tripathi S, Arora T, Singh A (2025) Adropin ameliorates reproductive dysfunctions in letrozole-induced PCOS mouse. Sci Rep 15(1):8659. https:\/\/doi.org\/10.1038\/s41598-025-93215-x","journal-title":"Sci Rep"},{"key":"12896_CR20","doi-asserted-by":"publisher","unstructured":"Zhang S, Li J, Lv X, Pan G, Liu Q, Zheng L, Xu L (2025) Adropin-Driven Browning: Targeting M2 Macrophages to Combat PCOS. https:\/\/doi.org\/10.1016\/j.intimp.2025.114273. Int Immunopharmacol 149114273","DOI":"10.1016\/j.intimp.2025.114273"},{"key":"12896_CR21","doi-asserted-by":"publisher","unstructured":"Aslan O, Topal \u00d6nal H, Urhan K\u00fc\u00e7\u00fck M, Dirican E (2026) Adropin, S100A1, and SERCA2b Dysregulation in Coronary Artery Disease: Molecular and In Silico Insights into Calcium Signaling and Metabolic Dysfunction. Biomedicines 14(7). https:\/\/doi.org\/10.3390\/biomedicines14071430","DOI":"10.3390\/biomedicines14071430"},{"key":"12896_CR22","doi-asserted-by":"publisher","unstructured":"Thapa D, Stoner MW, Zhang M, Xie B, Manning JR, Guimaraes D, Shiva S, Jurczak MJ, Scott I (2018) Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway. Redox Biol 1825\u20131832. https:\/\/doi.org\/10.1016\/j.redox.2018.06.003","DOI":"10.1016\/j.redox.2018.06.003"},{"issue":"37","key":"12896_CR23","doi-asserted-by":"publisher","first-page":"25976","DOI":"10.1074\/jbc.M114.576058","volume":"289","author":"CM Wong","year":"2014","unstructured":"Wong CM, Wang Y, Lee JT, Huang Z, Wu D, Xu A, Lam KS (2014) Adropin is a brain membrane-bound protein regulating physical activity via the NB-3\/Notch signaling pathway in mice. J Biol Chem 289(37):25976\u201325986. https:\/\/doi.org\/10.1074\/jbc.M114.576058","journal-title":"J Biol Chem"},{"issue":"4","key":"12896_CR24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/oby.20631","volume":"22","author":"MP St-Onge","year":"2014","unstructured":"St-Onge MP, Shechter A, Shlisky J, Tam CS, Gao S, Ravussin E, Butler AA (2014) Fasting plasma adropin concentrations correlate with fat consumption in human females. Obes (Silver Spring) 22(4):1056\u20131063. https:\/\/doi.org\/10.1002\/oby.20631","journal-title":"Obes (Silver Spring)"},{"issue":"8","key":"12896_CR25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/oby.21557","volume":"24","author":"JR Stevens","year":"2016","unstructured":"Stevens JR, Kearney ML, St-Onge MP, Stanhope KL, Havel PJ, Kanaley JA, Thyfault JP, Weiss EP, Butler AA (2016) Inverse association between carbohydrate consumption and plasma adropin concentrations in humans. Obes (Silver Spring) 24(8):1731\u20131740. https:\/\/doi.org\/10.1002\/oby.21557","journal-title":"Obes (Silver Spring)"},{"issue":"25","key":"12896_CR26","doi-asserted-by":"publisher","first-page":"9706","DOI":"10.1074\/jbc.RA119.007528","volume":"294","author":"AA Butler","year":"2019","unstructured":"Butler AA, Zhang J, Price CA, Stevens JR, Graham JL, Stanhope KL, King S, Krauss RM, Bremer AA, Havel PJ (2019) Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates. J Biol Chem 294(25):9706\u20139719. https:\/\/doi.org\/10.1074\/jbc.RA119.007528","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"12896_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11010-013-1660-4","volume":"380","author":"S Aydin","year":"2013","unstructured":"Aydin S, Kuloglu T, Aydin S, Eren MN, Yilmaz M, Kalayci M, Sahin I, Kocaman N, Citil C, Kendir Y (2013) Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem 380(1\u20132):73\u201381. https:\/\/doi.org\/10.1007\/s11010-013-1660-4","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"12896_CR28","doi-asserted-by":"publisher","first-page":"H238","DOI":"10.1152\/ajpheart.00449.2020","volume":"320","author":"BAS Mushala","year":"2021","unstructured":"Mushala BAS, Scott I (2021) Adropin: a hepatokine modulator of vascular function and cardiac fuel metabolism. Am J Physiol Heart Circ Physiol 320(1):H238\u2013h244. https:\/\/doi.org\/10.1152\/ajpheart.00449.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"12896_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.12.002","author":"S Ghoshal","year":"2018","unstructured":"Ghoshal S, Stevens JR, Billon C, Girardet C, Sitaula S, Leon AS, Rao DC, Skinner JS, Rankinen T, Bouchard C et al (2018) Adropin: An endocrine link between the biological clock and cholesterol homeostasis. Mol Metab 851 \u2013 64. https:\/\/doi.org\/10.1016\/j.molmet.2017.12.002","journal-title":"Mol Metab 851 \u2013 64"},{"key":"12896_CR30","doi-asserted-by":"publisher","unstructured":"Meda C, Dolce A, Vegeto E, Maggi A, Della Torre S (2022) ER\u03b1-Dependent Regulation of Adropin Predicts Sex Differences in Liver Homeostasis during High-Fat Diet. Nutrients 14(16). https:\/\/doi.org\/10.3390\/nu14163262","DOI":"10.3390\/nu14163262"},{"key":"12896_CR31","doi-asserted-by":"publisher","unstructured":"Abulmeaty MMA, Almajwal AM, Razak S, Al-Ramadhan FR, Wahid RM (2023) Energy Homeostasis-Associated (Enho) mRNA Expression and Energy Homeostasis in the Acute Stress Versus Chronic Unpredictable Mild Stress Rat Models. Biomedicines 11(2). https:\/\/doi.org\/10.3390\/biomedicines11020440","DOI":"10.3390\/biomedicines11020440"},{"key":"12896_CR32","doi-asserted-by":"publisher","unstructured":"Skrzypski M, Ko\u0142odziejski PA, Pruszy\u0144ska-Oszma\u0142ek E, Wojciechowicz T, Janicka P, Kr\u0105\u017cek M, Ma\u0142ek E, Strowski MZ, Nowak KW (2022) Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum. Int J Mol Sci 23(17). https:\/\/doi.org\/10.3390\/ijms23179807","DOI":"10.3390\/ijms23179807"},{"issue":"40","key":"12896_CR33","doi-asserted-by":"publisher","first-page":"13753","DOI":"10.1074\/jbc.RA120.014381","volume":"295","author":"S Banerjee","year":"2020","unstructured":"Banerjee S, Ghoshal S, Stevens JR, McCommis KS, Gao S, Castro-Sepulveda M, Mizgier ML, Girardet C, Kumar KG, Galgani JE et al (2020) Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction. J Biol Chem 295(40):13753\u201313768. https:\/\/doi.org\/10.1074\/jbc.RA120.014381","journal-title":"J Biol Chem"},{"issue":"8","key":"12896_CR34","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1096\/fj.202000115RR","volume":"34","author":"X Chen","year":"2020","unstructured":"Chen X, Chen S, Shen T, Yang W, Chen Q, Zhang P, You Y, Sun X, Xu H, Tang Y et al (2020) Adropin regulates hepatic glucose production via PP2A\/AMPK pathway in insulin-resistant hepatocytes. Faseb j 34(8):10056\u201310072. https:\/\/doi.org\/10.1096\/fj.202000115RR","journal-title":"Faseb j"},{"key":"12896_CR35","doi-asserted-by":"publisher","unstructured":"Altamimi TR, Gao S, Karwi QG, Fukushima A, Rawat S, Wagg CS, Zhang L, Lopaschuk GD (2019) Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. https:\/\/doi.org\/10.1016\/j.metabol.2019.06.005. Metabolism 9837-48","DOI":"10.1016\/j.metabol.2019.06.005"},{"key":"12896_CR36","doi-asserted-by":"publisher","unstructured":"Kuo FY, Cheng KC, Li Y, Cheng JT, Tsai CC (2020) Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats. Diabetes Metab Syndr Obes 132269\u2013132277. https:\/\/doi.org\/10.2147\/dmso.s243755","DOI":"10.2147\/dmso.s243755"},{"key":"12896_CR37","doi-asserted-by":"publisher","unstructured":"Wang J, Ding N, Chen C, Gu S, Liu J, Wang Y, Lin L, Zheng Y, Li Y (2025) Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases. Front Immunol 161482308. https:\/\/doi.org\/10.3389\/fimmu.2025.1482308","DOI":"10.3389\/fimmu.2025.1482308"},{"issue":"1","key":"12896_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40200-022-01020-4","volume":"21","author":"N Rezaeinezhad","year":"2022","unstructured":"Rezaeinezhad N, Alizadeh R, Ghanbari-Niaki A (2022) Short-term circuit resistance training improves insulin resistance probably via increasing circulating Adropin. J Diabetes Metab Disord 21(1):583\u2013588. https:\/\/doi.org\/10.1007\/s40200-022-01020-4","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"12896_CR39","doi-asserted-by":"publisher","first-page":"20540","DOI":"10.1038\/s41598-023-48056-x","volume":"13","author":"R Nematbakhsh","year":"2023","unstructured":"Nematbakhsh R, Hajhashemy Z, Lotfi K, Shahdadian F, Rouhani P, Saneei P (2023) Association between dietary insulin index and load with brain derived neurotrophic factor, adropin and metabolic health status in Iranian adults. Sci Rep 13(1):20540. https:\/\/doi.org\/10.1038\/s41598-023-48056-x","journal-title":"Sci Rep"},{"issue":"6","key":"12896_CR40","doi-asserted-by":"publisher","first-page":"R476","DOI":"10.1152\/ajpregu.00511.2015","volume":"310","author":"LM Stein","year":"2016","unstructured":"Stein LM, Yosten GL, Samson WK (2016) Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19. Am J Physiol Regul Integr Comp Physiol 310(6):R476\u2013R480. https:\/\/doi.org\/10.1152\/ajpregu.00511.2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"12896_CR41","doi-asserted-by":"publisher","unstructured":"Yang F, Zhou L, Qian X, Wang D, He WJ, Tang ZW, Yin J, Huang QY (2017) Adropin Is a Key Mediator of Hypoxia Induced Anti-Dipsogenic Effects via TRPV4-CamKK-AMPK Signaling in the Circumventricular Organs of Rats. Front Mol Neurosci 10105. https:\/\/doi.org\/10.3389\/fnmol.2017.00105","DOI":"10.3389\/fnmol.2017.00105"},{"issue":"7","key":"12896_CR42","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.bbamcr.2017.05.001","volume":"1864","author":"A Rao","year":"2017","unstructured":"Rao A, Herr DR (2017) G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells. Biochim Biophys Acta Mol Cell Res 1864(7):1318\u20131327. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.05.001","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"3","key":"12896_CR43","first-page":"245","volume":"19","author":"R Akc\u0131lar","year":"2016","unstructured":"Akc\u0131lar R, Emel Ko\u00e7ak F, \u015eim\u015fek H, Akc\u0131lar A, Bayat Z, Ece E, K\u00f6kda\u015fgil H (2016) The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia. Iran J Basic Med Sci 19(3):245\u2013251","journal-title":"Iran J Basic Med Sci"},{"key":"12896_CR44","doi-asserted-by":"publisher","unstructured":"Jasaszwili M, Wojciechowicz T, Billert M, Strowski MZ, Nowak KW, Skrzypski M (2019) Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes. Mol Cell Endocrinol 496110532. https:\/\/doi.org\/10.1016\/j.mce.2019.110532","DOI":"10.1016\/j.mce.2019.110532"},{"key":"12896_CR45","doi-asserted-by":"publisher","unstructured":"Shahjouei S, Ansari S, Pourmotabbed T, Zand R (2016) Potential Roles of Adropin in Central Nervous System: Review of Current Literature. Front Mol Biosci 325. https:\/\/doi.org\/10.3389\/fmolb.2016.00025","DOI":"10.3389\/fmolb.2016.00025"},{"key":"12896_CR46","doi-asserted-by":"publisher","unstructured":"Butler AA, Havel PJ (2025) Adropin: A cardio-metabolic hormone in the periphery, a neurohormone in the brain? Peptides 187171391. https:\/\/doi.org\/10.1016\/j.peptides.2025.171391","DOI":"10.1016\/j.peptides.2025.171391"},{"issue":"6","key":"12896_CR47","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/jnc.14238","volume":"143","author":"L Yu","year":"2017","unstructured":"Yu L, Lu Z, Burchell S, Nowrangi D, Manaenko A, Li X, Xu Y, Xu N, Tang J, Dai H et al (2017) Adropin preserves the blood-brain barrier through a Notch1\/Hes1 pathway after intracerebral hemorrhage in mice. J Neurochem 143(6):750\u2013760. https:\/\/doi.org\/10.1111\/jnc.14238","journal-title":"J Neurochem"},{"issue":"2","key":"12896_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.47391\/jpma.20691","volume":"75","author":"S Akhlaq","year":"2025","unstructured":"Akhlaq S (2025) Time to broaden pharmacological treatment of cardiovascular disorders with physiological dimensions of Adropin. J Pak Med Assoc 75(2):275\u2013284. https:\/\/doi.org\/10.47391\/jpma.20691","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"12896_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12944-025-02703-6","volume":"24","author":"B Li","year":"2025","unstructured":"Li B, Rao J, Hu W, Yang Y, Zhou Q, Wu Y, Liu F, Li P (2025) Adropin as a therapeutic candidate for HFpEF: evidence of oxidative stress mitigation via Nrf2\/HO-1 signaling. Lipids Health Dis 24(1):273. https:\/\/doi.org\/10.1186\/s12944-025-02703-6","journal-title":"Lipids Health Dis"},{"issue":"6","key":"12896_CR50","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s12265-022-10248-7","volume":"15","author":"L Li","year":"2022","unstructured":"Li L, Xie W (2022) LncRNA HDAC11-AS1 Suppresses Atherosclerosis by Inhibiting HDAC11-Mediated Adropin Histone Deacetylation. J Cardiovasc Transl Res 15(6):1256\u20131269. https:\/\/doi.org\/10.1007\/s12265-022-10248-7","journal-title":"J Cardiovasc Transl Res"},{"issue":"7","key":"12896_CR51","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1042\/cs20261501","volume":"140","author":"BAS Mushala","year":"2026","unstructured":"Mushala BAS, Stoner MW, Sharifi-Sanjani M, Manning JR, Bugga P, Bhattarai N, McMahon B, Vandevender A, Mullet SJ, Kaufman BA et al (2026) Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF model. Clin Sci (Lond) 140(7):1399\u20131414. https:\/\/doi.org\/10.1042\/cs20261501","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"12896_CR52","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3892\/etm.2021.9992","volume":"21","author":"L Wang","year":"2021","unstructured":"Wang L, Zhao LP, Chen YQ, Chang XS, Xiong H, Zhang DM, Xu WT, Chen JC (2021) Adropin inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK\/ACC signaling pathway. Exp Ther Med 21(6):560. https:\/\/doi.org\/10.3892\/etm.2021.9992","journal-title":"Exp Ther Med"},{"issue":"2","key":"12896_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/joe-20-0077","volume":"246","author":"C Zhang","year":"2020","unstructured":"Zhang C, Zhang Q, Huang Z, Jiang Q (2020) Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation. J Endocrinol 246(2):109\u2013122. https:\/\/doi.org\/10.1530\/joe-20-0077","journal-title":"J Endocrinol"},{"key":"12896_CR54","doi-asserted-by":"publisher","unstructured":"Dodd WS, Patel D, Laurent D, Lucke-Wold B, Hosaka K, Johnson RD, Chalouhi N, Butler AA, Candelario-Jalil E, Hoh BL (2024) Subarachnoid hemorrhage-associated brain injury and neurobehavioral deficits are reversed with synthetic adropin treatment through sustained Ser1179 phosphorylation of endothelial nitric oxide synthase. Front Stroke 3. https:\/\/doi.org\/10.3389\/fstro.2024.1371140","DOI":"10.3389\/fstro.2024.1371140"},{"issue":"5","key":"12896_CR55","doi-asserted-by":"publisher","first-page":"657","DOI":"10.5650\/jos.ess21019","volume":"70","author":"L He","year":"2021","unstructured":"He L, Zhang FJ, Li HY, Li L, Song LG, Mao Y, Li J, Liu HM, Li FL, Xu LY et al (2021) Anti-diabetic Role of Adropin in Streptozotocin Induced Diabetic Rats via Alteration of PI3K\/Akt and Insulin Signaling Pathway. J Oleo Sci 70(5):657\u2013664. https:\/\/doi.org\/10.5650\/jos.ess21019","journal-title":"J Oleo Sci"},{"key":"12896_CR56","doi-asserted-by":"publisher","unstructured":"Li B, Wang Z, He Y, Chen T, Zhang Y, Yuan X, Li P (2022) Adropin Improves Radiation-Induced Myocardial Injury via VEGFR2\/PI3K\/Akt Pathway. Oxid Med Cell Longev 20228230214. https:\/\/doi.org\/10.1155\/2022\/8230214","DOI":"10.1155\/2022\/8230214"},{"key":"12896_CR57","doi-asserted-by":"publisher","unstructured":"Yang C, Lavayen BP, Liu L, Sanz BD, DeMars KM, Larochelle J, Pompilus M, Febo M, Sun YY, Kuo YM et al (2021) Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism. Redox Biol 48102197. https:\/\/doi.org\/10.1016\/j.redox.2021.102197","DOI":"10.1016\/j.redox.2021.102197"},{"issue":"1","key":"12896_CR58","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/strokeaha.122.039628","volume":"54","author":"C Yang","year":"2023","unstructured":"Yang C, Liu L, Lavayen BP, Larochelle J, Gunraj RE, Butler AA, Candelario-Jalil E (2023) Therapeutic Benefits of Adropin in Aged Mice After Transient Ischemic Stroke via Reduction of Blood-Brain Barrier Damage. Stroke 54(1):234\u2013244. https:\/\/doi.org\/10.1161\/strokeaha.122.039628","journal-title":"Stroke"},{"issue":"1","key":"12896_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41420-023-01697-3","volume":"9","author":"T Ying","year":"2023","unstructured":"Ying T, Wu L, Lan T, Wei Z, Hu D, Ke Y, Jiang Q, Fang J (2023) Adropin inhibits the progression of atherosclerosis in ApoE(-\/-)\/Enho(-\/-) mice by regulating endothelial-to-mesenchymal transition. Cell Death Discov 9(1):402. https:\/\/doi.org\/10.1038\/s41420-023-01697-3","journal-title":"Cell Death Discov"},{"issue":"5","key":"12896_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11011-025-01654-2","volume":"40","author":"S Namulodi","year":"2025","unstructured":"Namulodi S, Torun IE, Bayiroglu F, Kaya MS, Kilinc E (2025) Adropin ameliorates behavioral seizures and the relevant neuroinflammation, oxidative stress, and neural damage in a rat model of pentylenetetrazole-induced seizure potentially by reducing the activation of NF-\u03baB\/IkB-\u03b1 signaling pathway. Metab Brain Dis 40(5):222. https:\/\/doi.org\/10.1007\/s11011-025-01654-2","journal-title":"Metab Brain Dis"},{"key":"12896_CR61","doi-asserted-by":"publisher","unstructured":"Chen IW, Lin CW, Lin CN, Chen ST (2025) Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression. Front Endocrinol (Lausanne) 161511730. https:\/\/doi.org\/10.3389\/fendo.2025.1511730","DOI":"10.3389\/fendo.2025.1511730"},{"key":"12896_CR62","doi-asserted-by":"publisher","unstructured":"Berezina TA, Berezin OO, Hoppe UC, Lichtenauer M, Berezin AE (2024) Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides. Diagnostics (Basel) 14(16). https:\/\/doi.org\/10.3390\/diagnostics14161728","DOI":"10.3390\/diagnostics14161728"},{"key":"12896_CR63","doi-asserted-by":"publisher","unstructured":"Berezina TA, Berezin OO, Novikov EV, Berezin AE (2025) Low Levels of Adropin Predicted New Incidents of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction. Biomolecules 15(8). https:\/\/doi.org\/10.3390\/biom15081171","DOI":"10.3390\/biom15081171"},{"key":"12896_CR64","doi-asserted-by":"publisher","unstructured":"Youssef HS, Mohammed WH, Gazzar WBE, Farag AA, Khairat EH, Abdelmaksoud NE, Elkholy MA, Elalfy A, Ibrahim TA (2025) Adropin contributes to the nephro-protective effect of vitamin D in renal aging in a rat model via MAPK\/HIF\u03b1\/VEGF\/eNOS mechanism. J Nutr Biochem 143109957. https:\/\/doi.org\/10.1016\/j.jnutbio.2025.109957","DOI":"10.1016\/j.jnutbio.2025.109957"},{"issue":"47","key":"12896_CR65","doi-asserted-by":"publisher","first-page":"28540","DOI":"10.1074\/jbc.M115.652586","volume":"290","author":"SK Tiwari","year":"2015","unstructured":"Tiwari SK, Seth B, Agarwal S, Yadav A, Karmakar M, Gupta SK, Choubey V, Sharma A, Chaturvedi RK (2015) Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-\u03b2 Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)\/Akt\/Wnt\/\u03b2-Catenin Pathway. J Biol Chem 290(47):28540\u201328558. https:\/\/doi.org\/10.1074\/jbc.M115.652586","journal-title":"J Biol Chem"},{"issue":"8","key":"12896_CR66","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2174\/0929867324666170404142450","volume":"25","author":"G Xu","year":"2018","unstructured":"Xu G, Huang K, Zhou J (2018) Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products. Curr Med Chem 25(8):889\u2013907. https:\/\/doi.org\/10.2174\/0929867324666170404142450","journal-title":"Curr Med Chem"},{"key":"12896_CR67","doi-asserted-by":"publisher","unstructured":"Sato K, Yamashita T, Shirai R, Shibata K, Okano T, Yamaguchi M, Mori Y, Hirano T, Watanabe T (2018) Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation. Int J Mol Sci 19(5). https:\/\/doi.org\/10.3390\/ijms19051293","DOI":"10.3390\/ijms19051293"},{"issue":"8","key":"12896_CR68","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2310\/jim.0000000000000003","volume":"61","author":"M Topuz","year":"2013","unstructured":"Topuz M, Celik A, Aslantas T, Demir AK, Aydin S, Aydin S (2013) Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. J Investig Med 61(8):1161\u20131164. https:\/\/doi.org\/10.2310\/jim.0000000000000003","journal-title":"J Investig Med"},{"issue":"5","key":"12896_CR69","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1515\/cclm-2013-0844","volume":"52","author":"L Wu","year":"2014","unstructured":"Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, Fan L (2014) Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med 52(5):751\u2013758. https:\/\/doi.org\/10.1515\/cclm-2013-0844","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"12896_CR70","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/oby.23249","volume":"29","author":"AA Butler","year":"2021","unstructured":"Butler AA, Havel PJ (2021) Adropin and insulin resistance: Integration of endocrine, circadian, and stress signals regulating glucose metabolism. Obes (Silver Spring) 29(11):1799\u20131801. https:\/\/doi.org\/10.1002\/oby.23249","journal-title":"Obes (Silver Spring)"},{"issue":"4","key":"12896_CR71","doi-asserted-by":"publisher","first-page":"412","DOI":"10.22141\/2224-0721.22.4.2026.1727","volume":"22","author":"H Al-Saeed","year":"2026","unstructured":"Al-Saeed H H (2026) Adropin, nesfatin-1, and sex hormones as metabolic-endocrine biomarkers in prostate cancer development. Int J Endocrinol (Ukraine) 22(4):412\u2013417. https:\/\/doi.org\/10.22141\/2224-0721.22.4.2026.1727","journal-title":"Int J Endocrinol (Ukraine)"},{"issue":"3","key":"12896_CR72","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4103\/njcp.njcp_509_25","volume":"29","author":"B Coskun","year":"2026","unstructured":"Coskun B, Dizdar OS, Cak\u0131r I, Koc A (2026) Circulating Adropin and Preptin Levels in Non-alcoholic Steatohepatitis and Their Relationship with Carotid Intima Media Thickness: A Cross-Sectional Study from T\u00fcrkiye. Niger J Clin Pract 29(3):266\u2013272. https:\/\/doi.org\/10.4103\/njcp.njcp_509_25","journal-title":"Niger J Clin Pract"},{"issue":"8","key":"12896_CR73","doi-asserted-by":"publisher","first-page":"e14043","DOI":"10.14814\/phy2.14043","volume":"7","author":"D Thapa","year":"2019","unstructured":"Thapa D, Xie B, Manning JR, Zhang M, Stoner MW, Huckestein BR, Edmunds LR, Zhang X, Dedousis NL, O\u2019Doherty RM et al (2019) Adropin reduces blood glucose levels in mice by limiting hepatic glucose production. Physiol Rep 7(8):e14043. https:\/\/doi.org\/10.14814\/phy2.14043","journal-title":"Physiol Rep"},{"issue":"7","key":"12896_CR74","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00592-023-02082-3","volume":"60","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wu X, Li X, Chang X, Ding X, Wang Q, Jiang T, Wang G, Liu J (2023) Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease. Acta Diabetol 60(7):971\u2013979. https:\/\/doi.org\/10.1007\/s00592-023-02082-3","journal-title":"Acta Diabetol"},{"issue":"1","key":"12896_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42000-021-00331-0","volume":"21","author":"S Soltani","year":"2022","unstructured":"Soltani S, Kolahdouz-Mohammadi R, Aydin S, Yosaee S, Clark CCT, Abdollahi S (2022) Circulating levels of adropin and overweight\/obesity: a systematic review and meta-analysis of observational studies. Horm (Athens) 21(1):15\u201322. https:\/\/doi.org\/10.1007\/s42000-021-00331-0","journal-title":"Horm (Athens)"},{"issue":"2","key":"12896_CR76","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/1557988316664074","volume":"11","author":"S Yosaee","year":"2017","unstructured":"Yosaee S, Khodadost M, Esteghamati A, Speakman JR, Shidfar F, Nazari MN, Bitarafan V, Djafarian K (2017) Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight\/Obese and Lean Subjects. Am J Mens Health 11(2):426\u2013434. https:\/\/doi.org\/10.1177\/1557988316664074","journal-title":"Am J Mens Health"},{"issue":"12","key":"12896_CR77","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/ame2.70092","volume":"8","author":"II Ali","year":"2025","unstructured":"Ali II, D\u2019Souza C, Nemmar A, Ojha S, Adeghate EA (2025) Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus. Anim Model Exp Med 8(12):2139\u20132154. https:\/\/doi.org\/10.1002\/ame2.70092","journal-title":"Anim Model Exp Med"},{"key":"12896_CR78","doi-asserted-by":"publisher","unstructured":"Ali II, D\u2019Souza C, Tariq S, Adeghate EA (2024) Adropin Is Expressed in Pancreatic Islet Cells and Reduces Glucagon Release in Diabetes Mellitus. Int J Mol Sci 25(18). https:\/\/doi.org\/10.3390\/ijms25189824","DOI":"10.3390\/ijms25189824"},{"key":"12896_CR79","doi-asserted-by":"publisher","unstructured":"Billert M, Jasaszwili M, Strowski M, Nowak KW, Skrzypski M (2020) Adropin suppresses insulin expression and secretion in INS-1E cells and rat pancreatic islets. J Physiol Pharmacol 71(1). https:\/\/doi.org\/10.26402\/jpp.2020.1.09","DOI":"10.26402\/jpp.2020.1.09"},{"key":"12896_CR80","doi-asserted-by":"publisher","unstructured":"Karap\u0131nar G\u00f6ze E, \u00dcr\u00fcn \u00dcnal B, \u00dcnl\u00fc A, A\u00e7\u0131lan \u0130 (2026) Beyond glycemia: adropin, asprosin, and irisin as potential biomarkers for cardiovascular risk in diabetes and prediabetes. Sci Rep 16(1). https:\/\/doi.org\/10.1038\/s41598-026-37306-3","DOI":"10.1038\/s41598-026-37306-3"},{"key":"12896_CR81","doi-asserted-by":"publisher","unstructured":"Sivakumar R, Aravaanan ASK, Mohanakrishnan VV, Kumar J (2026) Adropin and Endothelin-1 as Complementary Signals Associated with Early Vascular Aging in Middle-Aged Type 2 Diabetes. Diseases 14(4). https:\/\/doi.org\/10.3390\/diseases14040140","DOI":"10.3390\/diseases14040140"},{"issue":"12","key":"12896_CR82","first-page":"1568","volume":"45","author":"S Yosaee","year":"2016","unstructured":"Yosaee S, Soltani S, Sekhavati E, Jazayeri S (2016) Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article. Iran J Public Health 45(12):1568\u20131576","journal-title":"Iran J Public Health"},{"issue":"1","key":"12896_CR83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12882-025-04087-2","volume":"26","author":"C Guven","year":"2025","unstructured":"Guven C, Ko\u00e7ak S, Karadag A, Ayd\u0131n H, Yalcin A, Turk A (2025) Adropin as a protective agent against renal ischemia-reperfusion injury induced by suprarenal aortic cross-clamping in rats. BMC Nephrol 26(1):154. https:\/\/doi.org\/10.1186\/s12882-025-04087-2","journal-title":"BMC Nephrol"},{"key":"12896_CR84","doi-asserted-by":"publisher","unstructured":"Kaur R, Krishan P, Kumari P, Singh T, Singh V, Singh R, Ahmad SF (2023) Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease. Diagnostics (Basel) 13(19). https:\/\/doi.org\/10.3390\/diagnostics13193158","DOI":"10.3390\/diagnostics13193158"},{"issue":"1","key":"12896_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41514-023-00122-4","volume":"9","author":"G Aggarwal","year":"2023","unstructured":"Aggarwal G, Malmstrom TK, Morley JE, Miller DK, Nguyen AD, Butler AA (2023) Low circulating adropin levels in late-middle aged African Americans with poor cognitive performance. NPJ Aging 9(1):24. https:\/\/doi.org\/10.1038\/s41514-023-00122-4","journal-title":"NPJ Aging"},{"issue":"1","key":"12896_CR86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s11357-023-00824-3","volume":"46","author":"G Aggarwal","year":"2024","unstructured":"Aggarwal G, Morley JE, Vellas B, Nguyen AD, Butler AA (2024) Low circulating adropin concentrations predict increased risk of cognitive decline in community-dwelling older adults. Geroscience 46(1):897\u2013911. https:\/\/doi.org\/10.1007\/s11357-023-00824-3","journal-title":"Geroscience"},{"key":"12896_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-026-00426-1","author":"AA Butler","year":"2026","unstructured":"Butler AA, Graham JL, Ceniceros LC, Cruz AM, Cunningham AD, Subedi R, Brown AP, Dai N, Diniz GB, Havel PJ et al (2026) Low circulating adropin concentrations identify vulnerability in learning-dependent cognitive performance in aged rhesus macaques. NPJ Aging. https:\/\/doi.org\/10.1038\/s41514-026-00426-1","journal-title":"NPJ Aging"},{"issue":"37","key":"12896_CR88","doi-asserted-by":"publisher","first-page":"e27247","DOI":"10.1097\/md.0000000000027247","volume":"100","author":"U Cinkir","year":"2021","unstructured":"Cinkir U, Bir LS, Topsakal S, Avci Cicek E, Tekin S (2021) Investigation of blood leptin and adropin levels in patients with multiple sclerosis: A CONSORT-clinical study. Med (Baltim) 100(37):e27247. https:\/\/doi.org\/10.1097\/md.0000000000027247","journal-title":"Med (Baltim)"},{"issue":"6","key":"12896_CR89","doi-asserted-by":"publisher","first-page":"790","DOI":"10.22038\/ijbms.2025.82498.17830","volume":"28","author":"A Ozkan","year":"2025","unstructured":"Ozkan A, Parlak H, Sinen O, Bulbul M, Aydin Aslan M, Agar A (2025) Adropin exerts neuroprotection in an experimental rat model of Parkinson\u2019s disease. Iran J Basic Med Sci 28(6):790\u2013798. https:\/\/doi.org\/10.22038\/ijbms.2025.82498.17830","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"12896_CR90","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4274\/tjod.galenos.2021.12080","volume":"18","author":"E Akbaba","year":"2021","unstructured":"Akbaba E, Sezgin B, Edg\u00fcnl\u00fc T (2021) The role of adropin, salusin-\u03b1, netrin-1, and nesfatin-1 in endometriosis and their association with insulin resistance. Turk J Obstet Gynecol 18(3):175\u2013180. https:\/\/doi.org\/10.4274\/tjod.galenos.2021.12080","journal-title":"Turk J Obstet Gynecol"},{"issue":"1","key":"12896_CR91","doi-asserted-by":"publisher","first-page":"302","DOI":"10.55730\/1300-0144.6164","volume":"56","author":"E Eraslan","year":"2026","unstructured":"Eraslan E, Tanyeli A, G\u00fcler MC, \u00d6zbek Bilgin A, Ekinci Akdemir FN, Polat E, \u00c7omakli S, Kurt N, Bal Ta\u015ftan T (2026) Neuroendocrine effects of exogenous adropin administration on the hypothalamic pituitary testicular axis in male rats. Turk J Med Sci 56(1):302\u2013314. https:\/\/doi.org\/10.55730\/1300-0144.6164","journal-title":"Turk J Med Sci"},{"key":"12896_CR92","doi-asserted-by":"publisher","unstructured":"Rybska M, Czy\u017cewska-Dors E, Wojciechowicz T, Sowi\u0144ska N, \u0141ukomska A, Augustyniak A, Szygu\u0142a A, Gogulski M, W\u0105sowska B, Skrzypski M (2025) Expression of adropin in the reproductive organs of healthy female dogs and those with cystic endometrial hyperplasia, pyometra, and ovarian cysts. Vet J 314106478. https:\/\/doi.org\/10.1016\/j.tvjl.2025.106478","DOI":"10.1016\/j.tvjl.2025.106478"},{"issue":"3","key":"12896_CR93","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1194\/jlr.RA119000423","volume":"61","author":"AA Butler","year":"2020","unstructured":"Butler AA, Graham JL, Stanhope KL, Wong S, King S, Bremer AA, Krauss RM, Hamilton J, Havel PJ (2020) Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi. J Lipid Res 61(3):376\u2013386. https:\/\/doi.org\/10.1194\/jlr.RA119000423","journal-title":"J Lipid Res"},{"key":"12896_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2014.04.001","author":"HY Yu","year":"2014","unstructured":"Yu HY, Zhao P, Wu MC, Liu J, Yin W (2014) Serum adropin levels are decreased in patients with acute myocardial infarction. Regul Pept. https:\/\/doi.org\/10.1016\/j.regpep.2014.04.001. 190-19146-9","journal-title":"Regul Pept"},{"key":"12896_CR95","doi-asserted-by":"publisher","unstructured":"Liu M, Ai J, Shuai Z, Tang K, Li Z, Huang Y (2021) Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study. Front Cardiovasc Med 8688586. https:\/\/doi.org\/10.3389\/fcvm.2021.688586","DOI":"10.3389\/fcvm.2021.688586"},{"key":"12896_CR96","doi-asserted-by":"publisher","unstructured":"Liu M, Chen P, Wang S, Zeng G, Lv Z (2025) Adropin Alleviates High-Glucose-Induced Cardiomyocyte Apoptosis In Vitro via the Modulation of Mitophagy and Mitochondrial Dynamics. Int J Pharmacol 21(8). https:\/\/doi.org\/10.31083\/ijp46592","DOI":"10.31083\/ijp46592"},{"issue":"4","key":"12896_CR97","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1515\/tjb-2025-0201","volume":"50","author":"T Akda\u011f","year":"2025","unstructured":"Akda\u011f T, Uca AU, Alta\u015f M, Tokg\u00f6z OS, Odaba\u015f F\u00d6, \u0130bi\u015f S (2025) Serum adropin, clusterin, hemokinin-1, and kisspeptin levels in patients with migraine. Turkish J Biochem 50(4):530\u2013536. https:\/\/doi.org\/10.1515\/tjb-2025-0201","journal-title":"Turkish J Biochem"},{"issue":"9","key":"12896_CR98","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1248\/bpb.b25-00392","volume":"48","author":"N Tagawa","year":"2025","unstructured":"Tagawa N, Kato I, Asakawa A, Satoh A, Tanaka-Mizuno S (2025) Development of a Specific Competitive ELISA for Plasma Adropin Levels and Its Application to Investigating Energy Homeostasis in Mice. Biol Pharm Bull 48(9):1325\u20131334. https:\/\/doi.org\/10.1248\/bpb.b25-00392","journal-title":"Biol Pharm Bull"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12896-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12896-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12896-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:44:16Z","timestamp":1791668656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12896-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12896"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12896-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"23 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (Approval Code: IR.TBZMED.VCR.REC.1403.089).","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1709"}}